| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $64.98 | $39.22 | 65.70% | 43.03x | 30.60x | 7.19x | 8.53x | 0.59x | $194.62M | 2.81% | $833.74M | 7.82 | $7.02B | 63.31 | ||
| PGEN | PRECIGEN INC | $4.16 | $4.23 | -1.69% | 32.00x | 17.33x | 9.50x | 17.80x | 0.34x | -$74.32M | -4.98% | $83.79M | 0.23 | $1.58B | 38.54 | ||
| FENC | FENNEC PHARMACEUTICALS INC | $13.45 | $3.09 | 334.99% | 336.25x | 46.59x | 7.12x | 9.65x | 1.36x | $3.15M | 0.67% | $49.19M | 1.40 | $426.17M | 150.80 | ||
| TGTX | TG THERAPEUTICS INC | $64.88 | $20.22 | 220.88% | 83.18x | 63.29x | 10.17x | 17.14x | 1.15x | $85.56M | 0.94% | $572.13M | 4.06 | $10.13B | 51.59 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $27.17 | $7.88 | 244.69% | 123.50x | 87.70x | 7.00x | 14.08x | 1.17x | $59.71M | 1.68% | $243.97M | 1.86 | $3.52B | 75.16 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $286.94 | $72.05 | 298.22% | 108.28x | 29.59x | 22.57x | 5.97x | 1.41x | $90.43M | 1.58% | $961.76M | 48.18 | $6.83B | 69.42 | ||
| KRYS | KRYSTAL BIOTECH INC | $315.82 | $76.17 | 314.60% | 41.23x | 40.30x | 19.90x | 6.52x | 2.28x | $310.08M | 3.32% | $1.44B | 48.48 | $8.90B | 33.53 | ||
| RPRX | ROYALTY PHARMA PLC | $67.72 | $34.58 | 95.85% | 44.26x | 12.38x | 11.54x | 3.97x | 0.73x | $2.89B | 9.58% | $9.80B | 21.96 | $46.92B | 44.96 | ||
| HALO | HALOZYME THERAPEUTICS INC | $93.04 | $73.85 | 25.98% | 21.94x | 10.27x | 5.87x | -192.03x | 0.51x | $885.88M | 8.37% | -$55.24M | -0.49 | $12.83B | 15.92 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $93.54 | $14.40 | 549.46% | 65.41x | 71.28x | 7.73x | 10.35x | 3.54x | $197.20M | 2.70% | $710.19M | 9.08 | $7.28B | 47.86 | ||
| VCEL | VERICEL CORP | $58.26 | $8.42 | 592.04% | 88.27x | 77.19x | 9.20x | 7.74x | 3.20x | $57.89M | 1.94% | $384.17M | 7.51 | $2.93B | 54.33 | ||
| ADMA | ADMA BIOLOGICS INC | $13.34 | $6.82 | 95.69% | 16.89x | 16.55x | 5.75x | 6.75x | 1.24x | $132.91M | 4.45% | $438.51M | 1.96 | $3.03B | 12.00 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $236.45 | $128.89 | 83.45% | 64.96x | 15.48x | 3.24x | 3.62x | 0.62x | $1.65B | 10.81% | $4.19B | 64.79 | $18.77B | 16.38 | ||
| TECH | BIO-TECHNE CORP | $72.70 | $15.94 | 356.08% | 66.09x | 35.00x | 9.28x | 5.27x | 1.97x | $308.20M | 2.70% | $2.17B | 13.81 | $11.36B | 34.02 | ||
| EXEL | EXELIXIS INC | $65.83 | $31.14 | 111.38% | 19.08x | 18.80x | 6.51x | 8.76x | 1.28x | $1.16B | 7.15% | $1.83B | 7.43 | $15.92B | 14.25 | ||
| INCY | INCYTE CORP | $115.87 | $52.57 | 120.43% | 55.44x | 33.57x | 3.92x | 4.19x | 0.80x | $684.87M | 2.91% | $5.64B | 27.76 | $20.37B | 22.71 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $520.66 | $143.51 | 262.81% | 33.23x | 28.01x | 10.19x | 6.31x | 2.16x | $3.20B | 2.43% | $20.91B | 82.48 | $133.51B | 26.51 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.07 | $7.82 | 15.95% | 7.14x | 7.94x | 3.65x | 2.26x | 1.37x | $87.07M | 16.16% | $238.92M | 4.02 | $418.79M | 4.36 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $923.34 | $482.93 | 91.19% | 19.64x | 13.15x | 5.56x | 2.85x | 1.03x | $3.83B | 4.07% | $33.50B | 329.39 | $94.57B | 15.14 | ||
| UTHR | UNITED THERAPEUTICS CORP | $559.10 | $207.86 | 168.98% | 19.57x | 20.88x | 7.49x | 3.79x | 2.18x | $867.20M | 3.63% | $6.28B | 146.98 | $22.62B | 14.00 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $32.98 | $27.97 | 17.93% | 10.67x | 8.60x | 1.95x | 1.81x | 0.71x | $322.93M | 16.76% | $1.07B | 18.36 | $1.44B | 5.30 | ||
| VCYT | VERACYTE INC | $25.04 | $9.54 | 162.44% | 15.75x | 12.79x | 3.46x | 1.41x | 3.37x | $161.95M | 8.04% | $1.43B | 17.80 | $1.86B | 13.04 |